Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ranjeet Singh Mahla und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK. Hauptthemen laut MEDLINE: Ribonucleoproteins, Rheumatic Diseases, Inflammation, Autoimmune Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bristol-Myers Squibb (United States), EULAR, Oxford–Bristol Myers Squibb–Celgene Research Fellowship Programme.
Abstract (Originalsprache)
The Ro60/SSA2 autoantigen is an RNA-binding protein and a core component of nucleocytoplasmic ribonucleoprotein (RNP) complexes. Ro60 is essential in RNA metabolism, cell stress response pathways, and cellular homeostasis. It stabilises and mediates the quality control and cellular distribution of small RNAs, including YRNAs (for the ‘y’ in ‘cytoplasmic’), retroelement transcripts, and misfolded RNAs. Ro60 transcriptional dysregulation or loss of function can result in the generation and release of RNA fragments from YRNAs and other small RNAs. Small RNA fragments can instigate an inflammatory cascade through endosomal toll-like receptors (TLRs) and cytoplasmic RNA sensors, which typically sense pathogen-associated molecular patterns, and mount the first line of defence against invading pathogens. However, the recognition of host-originating RNA moieties from Ro60 RNP complexes can activate inflammatory response pathways and compromise self-tolerance. Autoreactive B cells may produce antibodies targeting extracellular Ro60 RNP complexes. Ro60 autoantibodies serve as diagnostic markers for various autoimmune diseases, including Sjögren’s disease (SjD) and systemic lupus erythematosus (SLE), and they may also act as predictive markers for anti-drug antibody responses among rheumatic patients. Understanding Ro60’s structure, function, and role in self-tolerance can enhance our understanding of the underlying molecular mechanisms of autoimmune conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.
ORCID-Profile: Ranjeet Singh Mahla, Esther L Jones, Lynn B Dustin
Förderung
- Bristol-Myers Squibb (United States)
- EULAR
- Oxford–Bristol Myers Squibb–Celgene Research Fellowship Programme
- Kennedy Trust for Rheumatology Research
- Henni Mester Fellowship (University College, University of Oxford)
Zitieren
APA
Mahla, R. S., Jones, E. L., & Dustin, L. B. (2024). Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147705
Vancouver
Mahla RS, Jones EL, Dustin LB. Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147705
BibTeX
@article{Mahla2024,
author = {Mahla, Ranjeet Singh and Jones, Esther L and Dustin, Lynn B},
title = {Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147705}
}
EUVIMED